Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-004477
Filing Date
2025-01-17
Accepted
2025-01-17 16:13:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 tm252887-4_424b3.htm 424B3 247078
2 GRAPHIC lg_markertherap-4clr.jpg GRAPHIC 18747
3 GRAPHIC tb_overview-4clr.jpg GRAPHIC 89723
4 GRAPHIC tb_pipeline-4clr.jpg GRAPHIC 45301
  Complete submission text file 0001104659-25-004477.txt   457791
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284233 | Film No.: 25538801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)